Rare event flow cytometry requires more than simply collecting enough cells.

Accurately detecting low-frequency cell populations depends on thoughtful assay design, optimized gating strategies, and statistical confidence. This webinar discusses the key considerations for developing robust flow cytometry assays that generate reliable rare event data for research, clinical laboratories, and advanced therapeutic development.

Topics include:

• Selecting appropriate parameters and gating strategies to identify rare cell populations
• Improving assay precision and signal-to-noise for greater confidence in rare event detection
• Applying statistical approaches to support accurate interpretation of rare cell populations
• Using rare event flow cytometry to support immunotherapy research, including CAR T-cell development

As advanced cell therapies continue to expand, robust rare event detection is essential for generating high-quality analytical data. Discover practical approaches for optimizing flow cytometry assays to support confident decision-making throughout clinical development.